Research Grants for Clinical Studies of Kidney Diseases
The summary for the Research Grants for Clinical Studies of Kidney Diseases grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Research Grants for Clinical Studies of Kidney Diseases: The Division of Kidney, Urologic, and Hematologic Diseases of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has a longstanding and substantial interest in research concerning the prevention and treatment of kidney disorders. This program announcement (PAR) is a re- issuance of PAR 03-105, and specifically encourages the submission of applications for pilot and feasibility studies, clinical trials, and epidemiological studies related to kidney disease research that are particularly innovative and/or potentially of high impact. It is anticipated that applications for pilot and feasibility studies may lead to full-scale clinical trials in the prevention, diagnosis or treatment of kidney disease. These grants may be used for trials that evaluate pharmacological, dietary, surgical, or behavioral interventions for the prevention or treatment of kidney disease. In view of the extent and severity of various co-morbidities (i.e., cardiovascular disease, infections, and depression) observed in patients with kidney disease, these grants may also assess interventions that prevent or treat co-morbid conditions in the setting of renal disease. Pilot epidemiological studies are also encouraged, especially related to kidney disease, or co-morbid condition, prevention. It is anticipated that these grants will in some cases serve as a basis of planning future multi-center research project grant applications (R01) or for cooperative agreement (U01) applications. Both new and experienced investigators in relevant fields and disciplines are encouraged to apply for these grants.
|Federal Grant Title:||Research Grants for Clinical Studies of Kidney Diseases|
|Federal Agency Name:||National Institutes of Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||PAR-04-065|
|Type of Funding:||Grant|
|CFDA Descriptions:||Kidney Diseases, Urology and Hematology Research|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||July 19, 2004, March 18, 2005|
|Posted Date:||Feb 23, 2004|
|Creation Date:||Feb 23, 2004|
|Archive Date:||Apr 17, 2005|
|Total Program Funding:|
|Maximum Federal Grant Award:|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification) State governments County governments City or township governments Special district governments Independent school districts
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
- Similar Government Grants
- • Investigations on Primary Immunodeficiency Diseases (R01)
- • Grants for Basic Research in Glomerular Diseases (R01)
- • Advances in Polycystic Kidney Disease (R01)
- • Ancillary Studies of Kidney Disease Accessing Information from Clinical Trials, Epidemiolo...
- • Calcium Oxalate Stone Diseases (R01)
- • Chronic Prostatitis Collaborative Research Network (Cpcrn)
- • Frequent Hemodialysis Clinical Trials
- • Noninvasive Measurement of Iron by Magnetic Resonance Imaging (Sbir/Sttr)
- More Grants from the National Institutes of Health
- • Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource...
- • Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24)...
- • New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not...
- • Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...
- • Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Tria...